Skip to search formSkip to main contentSkip to account menu

Rifamycins

Known as: Rifamycin, Rifamycins [Chemical/Ingredient], 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-B)furan-1,11(2h)-dione 21-Acetate 
A natural antibiotic produced by Streptomyces mediterranei, Rifamycin (Ansamycin Family) is a commonly used antimycobacterial drug that inhibits… 
National Institutes of Health

Related topics

Related topics

46 relations

Narrower (34)

27-O-demethylrifamycin S3-hydrazinorifamycinABI 0043ABI 1131

Broader (3)

Anti-Bacterial AgentsAntibioticsNaphthols
In BloodPoisoning by rifamycinsRifampinagonists

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae
SUMMARY Escherichia coli sequence type 131 (ST131) and Klebsiella pneumoniae ST258 emerged in the 2000s as important human… 
Review
2009
Review
2009
Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine…
This report updates and combines earlier versions of guidelines for the prevention and treatment of opportunistic infections (OIs… 
Review
2008
Review
2008
Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe.
Extended-spectrum beta-lactamases (ESBLs) represent a major threat among resistant bacterial isolates. The first types described… 
Review
2004
Review
2004
H pylori antibiotic resistance: prevalence, importance, and advances in testing
The discovery that Helicobacter pylori infection is the main cause of most gastroduodenal diseases has been a major breakthrough… 
Highly Cited
2002
Highly Cited
2002
Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals.
Nine clinical isolates of Enterobacteriaceae (six Escherichia coli and three Proteus mirabilis) isolated in three Parisian… 
Review
2001
Review
2001
Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials
The rifamycin antibacterials, rifampicin (rifampin), rifabutin and rifapentine, are uniquely potent in the treatment of patients… 
Highly Cited
2000
Highly Cited
2000
Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.
Review
1998
Review
1998
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.
Knowledge of the molecular genetic basis of resistance to antituberculous agents has advanced rapidly since we reviewed this… 
Highly Cited
1994
Highly Cited
1994
Antimicrobial therapy in veterinary medicine
Highly Cited
1974
Highly Cited
1974
ANTIBIOTIC AND CHEMOTHERAPY
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)